ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)
China · Delayed Price · Currency is CNY 29.46
-0.39 (-1.31%)
Sep 14, 2026, 3:00 PM CST
SHA:603976 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 718.87 | 662.26 | 797.8 | 896.9 | 793.01 | 793.62 |
Other Revenue | 2.42 | 2.12 | 3.33 | 3.74 | 3.19 | 3.04 |
| 721.29 | 664.37 | 801.12 | 900.65 | 796.2 | 796.66 | |
Revenue Growth | 8.62% | -17.07% | -11.05% | 13.12% | -0.06% | 58.70% |
Cost of Revenue | 615.55 | 556.42 | 655.95 | 759.02 | 642.95 | 598.3 |
Gross Profit | 105.74 | 107.95 | 145.18 | 141.63 | 153.25 | 198.36 |
Selling, General & Admin | 55.44 | 55.36 | 55.51 | 57.13 | 57.46 | 58.93 |
Research & Development | 13.57 | 14.51 | 20.26 | 23.43 | 19.11 | 12.08 |
Other Operating Expenses | 13.3 | 8.86 | 0.02 | 9.32 | 9.54 | 9.22 |
Operating Expenses | 84.13 | 81.69 | 75.5 | 90.76 | 86.73 | 81.82 |
Operating Income | 21.62 | 26.26 | 69.67 | 50.87 | 66.52 | 116.54 |
Interest Expense | -21.68 | -21.31 | -20.95 | -21.26 | -19.61 | -13.08 |
Interest & Investment Income | 6.69 | 8.7 | 9.8 | 9.17 | 8.39 | 9.12 |
Currency Exchange Gain (Loss) | -1.16 | 0.28 | 0.07 | -0.25 | -0.04 | 0.73 |
Other Non Operating Income (Expenses) | -0.18 | -0.06 | -0.04 | -0.04 | -0.06 | 0.05 |
EBT Excluding Unusual Items | 5.3 | 13.87 | 58.56 | 38.49 | 55.2 | 113.37 |
Gain (Loss) on Sale of Investments | 1.9 | -0.05 | 0.47 | 1.05 | -0.94 | 4.76 |
Gain (Loss) on Sale of Assets | -0.66 | -0.83 | -5.3 | -0.19 | -1.32 | -0.53 |
Legal Settlements | - | - | - | - | - | -1.87 |
Other Unusual Items | 11.62 | 7.05 | 6.49 | 5.47 | 5.61 | 10.25 |
Pretax Income | 18.15 | 20.04 | 60.21 | 44.83 | 58.55 | 125.97 |
Income Tax Expense | 1.05 | 1.14 | 6.96 | 4.56 | -6.22 | 19.37 |
Net Income | 17.1 | 18.9 | 53.25 | 40.27 | 64.77 | 106.6 |
Net Income to Common | 17.1 | 18.9 | 53.25 | 40.27 | 64.77 | 106.6 |
Net Income Growth | -25.50% | -64.50% | 32.24% | -37.83% | -39.24% | 100.95% |
Shares Outstanding (Basic) | 144 | 145 | 152 | 149 | 151 | 150 |
Shares Outstanding (Diluted) | 144 | 145 | 152 | 149 | 151 | 150 |
Shares Change | -6.47% | -4.42% | 2.01% | -0.99% | 0.32% | -0.94% |
EPS (Basic) | 0.12 | 0.13 | 0.35 | 0.27 | 0.43 | 0.71 |
EPS (Diluted) | 0.12 | 0.13 | 0.35 | 0.27 | 0.43 | 0.71 |
EPS Growth | -20.35% | -62.86% | 29.63% | -37.21% | -39.44% | 102.86% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 95.49 | 109.38 | 40.2 | 104.22 | -237.66 | -32.58 |
Free Cash Flow Per Share | 0.66 | 0.75 | 0.26 | 0.70 | -1.58 | -0.22 |
Dividend Per Share | 0.290 | 0.290 | 0.346 | 0.200 | 0.060 | 0.308 |
Dividend Growth | 17.89% | -16.18% | 73.00% | 233.33% | -80.52% | 755.56% |
Gross Margin | 14.66% | 16.25% | 18.12% | 15.72% | 19.25% | 24.90% |
Operating Margin | 3.00% | 3.95% | 8.70% | 5.65% | 8.35% | 14.63% |
Profit Margin | 2.37% | 2.84% | 6.65% | 4.47% | 8.13% | 13.38% |
Free Cash Flow Margin | 13.24% | 16.46% | 5.02% | 11.57% | -29.85% | -4.09% |
EBITDA | 135.45 | 132.68 | 184.06 | 156.3 | 152.62 | 182.98 |
EBITDA Margin | 18.78% | 19.97% | 22.98% | 17.36% | 19.17% | 22.97% |
D&A For EBITDA | 113.84 | 106.42 | 114.39 | 105.43 | 86.11 | 66.45 |
EBIT | 21.62 | 26.26 | 69.67 | 50.87 | 66.52 | 116.54 |
EBIT Margin | 3.00% | 3.95% | 8.70% | 5.65% | 8.35% | 14.63% |
Effective Tax Rate | 5.77% | 5.68% | 11.56% | 10.17% | - | 15.38% |
Revenue as Reported | 721.29 | 664.37 | 801.12 | 900.65 | 796.2 | 796.66 |
Advertising Expenses | - | 1.22 | 1.05 | - | 0.6 | 2.02 |